242 related articles for article (PubMed ID: 12510866)
1. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies.
Juszczak M
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):823-34. PubMed ID: 12510866
[TBL] [Abstract][Full Text] [Related]
2. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
3. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies.
Juszczak M; Stempniak B
Brain Res Bull; 2003 Jan; 59(5):393-7. PubMed ID: 12507691
[TBL] [Abstract][Full Text] [Related]
4. Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin.
Roszczyk M; Juszczak M
Endokrynol Pol; 2014; 65(2):125-31. PubMed ID: 24802736
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of gonadotrophin-releasing hormone (GnRH), its analogues and melatonin.
Boczek-Leszczyk E; Stempniak B; Juszczak M
J Physiol Pharmacol; 2010 Aug; 61(4):459-66. PubMed ID: 20814074
[TBL] [Abstract][Full Text] [Related]
6. Role of tachykinin receptors and melatonin in oxitocin secretion from isolated rat hypothalmo-neurohypophysial system.
Juszczak M; Furykiewicz-Nykiś K; Stempniak B
J Physiol Pharmacol; 2004 Dec; 55(4):739-49. PubMed ID: 15613740
[TBL] [Abstract][Full Text] [Related]
7. The hypothalamo-neurohypophysial response to melatonin.
Juszczak M
Neuro Endocrinol Lett; 2001 Jun; 22(3):169-74. PubMed ID: 11449194
[TBL] [Abstract][Full Text] [Related]
8. Galanin influences on vasopressin and oxytocin release: in vitro studies.
Izdebska K; Ciosek J
Neuropeptides; 2010 Aug; 44(4):341-8. PubMed ID: 20466422
[TBL] [Abstract][Full Text] [Related]
9. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
Ciosek J; Cisowska A
J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
[TBL] [Abstract][Full Text] [Related]
10. Neurohypophysial response to peptides of the cholecystokinin family: in vivo and in vitro studies.
Morawska-Barszczewska J; Lewandowska A; Guzek JW
Pol J Pathol; 1994; 45(2):163-71. PubMed ID: 8062068
[TBL] [Abstract][Full Text] [Related]
11. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors.
Wodowska J; Ciosek J
Neuropeptides; 2014 Dec; 48(6):387-97. PubMed ID: 25464889
[TBL] [Abstract][Full Text] [Related]
12. tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.
Bojanowska E; Stempniak B
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):781-93. PubMed ID: 11785773
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin and oxytocin release and the thyroid function.
Ciosek J; Drobnik J
J Physiol Pharmacol; 2004 Jun; 55(2):423-41. PubMed ID: 15213363
[TBL] [Abstract][Full Text] [Related]
14. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach.
Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M
Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304
[TBL] [Abstract][Full Text] [Related]
15. Galanin affects vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in haemorrahaged rats.
Ciosek J; Cisowska A; Dabrowski R
J Physiol Pharmacol; 2003 Jun; 54(2):233-46. PubMed ID: 12832724
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic and neurohypophysial vasopressin and oxytocin content as influenced by haemorrhage in melatonin-treated male rats.
Juszczak M; K+opotowska A; Stempniak B; Guzek JW
Patol Pol; 1993; 44(2):55-9. PubMed ID: 8367209
[TBL] [Abstract][Full Text] [Related]
17. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
18. The role of the cAMP/PKA signalling pathway in the inhibitory influence of melatonin on oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system.
Juszczak M; Krzyminska A; Bojanowska E; Roszczyk M
Endokrynol Pol; 2018; 69(5):560-566. PubMed ID: 30074234
[TBL] [Abstract][Full Text] [Related]
19. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland.
Larsen PJ; Jukes KE; Chowdrey HS; Lightman SL; Jessop DS
Endocrinology; 1994 Apr; 134(4):1635-9. PubMed ID: 8137725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
